Hairy Cell Leukemia (HCL) Recruiting Phase 2 Trials for Cladribine (DB00242)

Also known as: Hairy-cell Leukemia / Hairy cell leukaemia / Hairy Cell Leukemia / Leukemia, Hairy Cell / Leukemic reticuloendotheliosis / Hairy cell leukemia (disorder) / Hairy cell leukemia (morphologic abnormality) / Hairy cell leukemia with failed remission / Leukemic reticuloendotheliosis -RETIRED- / Leukaemic reticuloendotheliosis / Leukemic reticuloendotheliosis NOS (disorder) / Leukemic reticuloendotheliosis of unspecified sites (disorder) / [M]Leukaemic reticuloendotheliosis

DBCOND0046776 (Hairy Cell Leukemia (HCL))Recruiting2 IdentifierTitlePurposeDrugs
NCT00923013Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell LeukemiaTreatment
NCT00412594Cladribine and Rituximab in Treating Patients With Hairy Cell LeukemiaTreatment